نتائج البحث - Chan, Arlene
- يعرض 1 - 20 نتائج من 22
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer حسب Coleman, Robert, Zhou, Ying, Jandial, Danielle, Cadieux, Benoit, Chan, Arlene
منشور في 2021نص -
4
-
5
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease حسب Chan, Arlene, Morey, Adrienne, Brown, Belinda, Hastrich, Diana, Willsher, Peter, Ingram, David
منشور في 2012نص -
6
-
7
Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib حسب Vogel, Charles, Chan, Arlene, Gril, Brunilde, Kim, Sung-Bae, Kurebayashi, Junichi, Liu, Li, Lu, Yen-Shen, Moon, Hanlim
منشور في 2010نص -
8
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer حسب De Boer, Richard H., Kotasek, Dusan, White, Shane, Koczwara, Bogda, Mainwaring, Paul, Chan, Arlene, Melara, Rebeca, Ye, Yining, Adewoye, Adeboye H., Sikorski, Robert, Kaufman, Peter A.
منشور في 2012نص -
9
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer حسب Dent, Rebecca A, Lindeman, Geoffrey J, Clemons, Mark, Wildiers, Hans, Chan, Arlene, McCarthy, Nicole J, Singer, Christian F, Lowe, Elizabeth S, Watkins, Claire L, Carmichael, James
منشور في 2013نص -
10
Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada حسب Charest, Maxime, Sharma, Malika, Chris, Allison, Schnubb, Alexandre, Knox, David C., Wilton, James, Shahin, Rita, Chan, Arlene, Mishra, Sharmistha, Grace, Daniel, Bayoumi, Ahmed M., Maxwell, John, Bogoch, Isaac I., Tan, Darrell H. S.
منشور في 2021نص -
11
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol حسب Sharma, Malika, Chris, Allison, Chan, Arlene, Knox, David C., Wilton, James, McEwen, Owen, Mishra, Sharmistha, Grace, Daniel, Rogers, Tim, Bayoumi, Ahmed M., Maxwell, John, Shahin, Rita, Bogoch, Isaac, Gilbert, Mark, Tan, Darrell H. S.
منشور في 2018نص -
12
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer حسب Burris, Howard A., Chan, Arlene, Bardia, Aditya, Thaddeus Beck, J., Sohn, Joohyuk, Neven, Patrick, Tripathy, Debu, Im, Seock-Ah, Chia, Stephen, Esteva, Francisco J., Hart, Lowell, Zarate, Juan Pablo, Ridolfi, Antonia, Lorenc, Karen Rodriguez, Yardley, Denise A.
منشور في 2021نص -
13
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study حسب Fasching, Peter A., Beck, J. Thaddeus, Chan, Arlene, De Laurentiis, Michele, Esteva, Francisco J., Jerusalem, Guy, Neven, Patrick, Pivot, Xavier, Bianchi, Giulia V., Martin, Miguel, Chandiwana, David, Lanoue, Brad, Ridolfi, Antonia, Wang, Yingbo, Rodriguez Lorenc, Karen, Nusch, Arnd
منشور في 2020نص -
14
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast... حسب Wolff, Antonio C., Lazar, Ann A., Bondarenko, Igor, Garin, August M., Brincat, Stephen, Chow, Louis, Sun, Yan, Neskovic-Konstantinovic, Zora, Guimaraes, Rodrigo C., Fumoleau, Pierre, Chan, Arlene, Hachemi, Soulef, Strahs, Andrew, Cincotta, Maria, Berkenblit, Anna, Krygowski, Mizue, Kang, Lih Lisa, Moore, Laurence, Hayes, Daniel F.
منشور في 2013نص -
15
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast C... حسب Baselga, José, Zamagni, Claudio, Gómez, Patricia, Bermejo, Begoña, Nagai, Shigenori E., Melichar, Bohuslav, Chan, Arlene, Mángel, Lászlo, Bergh, Jonas, Costa, Frederico, Gómez, Henry L., Gradishar, William J., Hudis, Clifford A., Rapoport, Bernardo L., Roché, Henri, Patricia, Maeda, Huang, Liping, Meinhardt, Gerold, Zhang, Joshua, Schwartzberg, Lee S.
منشور في 2017نص -
16
Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer... حسب Au, Heather-Jane, Eiermann, Wolfgang, Robert, Nicholas J., Pieńkowski, Tadeusz, Crown, John, Martin, Miguel, Pawlicki, Marek, Chan, Arlene, Mackey, John, Glaspy, John, Pintér, Tamás, Liu, Mei-Ching, Fornander, Tommy, Sehdev, Sandeep, Ferrero, Jean-Marc, Bée, Valerie, Santana, Maria J., Miller, Dave P., Lalla, Deepa, Slamon, Dennis J.
منشور في 2013نص -
17
Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negati... حسب Baselga, José, Gómez, Patricia, Greil, Richard, Braga, Sofia, Climent, Miguel A., Wardley, Andrew M., Kaufman, Bella, Stemmer, Salomon M., Pêgo, António, Chan, Arlene, Goeminne, Jean-Charles, Graas, Marie-Pascale, Kennedy, M. John, Ciruelos Gil, Eva Maria, Schneeweiss, Andreas, Zubel, Angela, Groos, Jutta, Melezínková, Helena, Awada, Ahmad
منشور في 2013نص -
18
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant... حسب Gianni, Luca, Mansutti, Mauro, Anton, Antonio, Calvo, Lourdes, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chacon, Jose Ignacio, Chan, Arlene, Morales, Serafin, Alvarez, Isabel, Plazaola, Arrate, Zambetti, Milvia, Redfern, Andrew D., Dittrich, Christian, Dent, Rebecca Alexandra, Magazzù, Domenico, De Fato, Raffaella, Valagussa, Pinuccia, Tusquets, Ignacio
منشور في 2018نص -
19
An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer حسب Vacirca, Jeffrey L., Chan, Arlene, Mezei, Klára, Adoo, Clarence S., Pápai, Zsuzsanna, McGregor, Kimberly, Okera, Meena, Horváth, Zsolt, Landherr, László, Hanslik, Jerzy, Hager, Steven J., Ibrahim, Emad N., Rostom, Makharadze, Bhat, Gajanan, Choi, Mi Rim, Reddy, Guru, Tedesco, Karen L., Agajanian, Richy, Láng, István, Schwartzberg, Lee S.
منشور في 2018نص -
20
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer حسب Ocaña, Alberto, Chacón, Jose Ignacio, Calvo, Lourdes, Antón, Antonio, Mansutti, Mauro, Albanell, Joan, Martínez, María Teresa, Lahuerta, Ainhara, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chan, Arlene, Morales, Serafin, Herranz, Jesús, Tusquets, Ignacio, Chiesa, Massimo, Caballero, Rosalía, Valagussa, Pinuccia, Bianchini, Giampaolo, Alba, Emilio, Gianni, Luca
منشور في 2022نص